Specialty Pharmacy

Caregivers need to carefully monitor comorbidities that accompany a COPD diagnosis.

Fenofibrate with 2-Deoxy-D-glucose shows success treating a variety of cancers.

Top news of the day from across the health care landscape.

Higher doses of radiation found as effective as lower dose radiation for breast cancer treatment.

Digestive hormone found to reduce liver fibrosis associated with cholestasis.

Protease inhibitors can frequently lead to cardiovascular disease, diabetes, and obesity.

Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, discusses the optimal use of technology and data to improve patient care in specialty pharmacies.

Pharmacists among 301 individuals charged for allegedly engaging in $900 million in false billings.

Top articles of the week from The American Journal of Pharmacy Benefits.

Findings will allow for improved screenings of drugs that treat MS.

Recent advances and updates in oncology and cancer drug development.

Engineering bacteria to deliver HIV-1 neutralizing antibodies at the site where the virus enters the body may offer a cost-effective barrier to HIV-1 transmission.

“You can put yourself out of business by getting into the specialty pharmacy business.”

Ryan White HIV/AIDS Program offers medical care and services for low income, uninsured, and underinsured individuals.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses improved communication among specialty drug manufacturers and health care providers.

Diet and physical activity found to decrease the risk of developing multiple cancer types.

Certain characteristics could potentially make patients more likely to need assistance with their medications.

Top news of the day from across the health care landscape.

Researchers evaluate the link between organ transplant and the increased likelihood of developing diabetes.

Edaravone previously granted Orphan Drug Designation by the FDA for amyotrophic lateral sclerosis.

Top articles of the week on Specialty Pharmacy Times.

Anti-TNF-a monoclonal antibody treats moderate-to-severe plaque psoriasis and moderate-to-severe rheumatoid arthritis.

ACOs found to generate modest savings on an annual per patient basis.

Family and friends of terminal patients may have overly optimistic expectations for survival.

Biosimilars show promise for treatment of treat autoimmune diseases and hematological cancers.

Docetaxel-induced peripheral neuropathy found in castrate-resistant metastatic prostate cancer.

Researchers explore the capability of natural killer cells.

Top news of the day from across the health care landscape.